369 related articles for article (PubMed ID: 10706679)
1. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
2. Significant role for Fas in the pathogenesis of autoimmune diabetes.
Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
Kim YH; Kim S; Kim KA; Yagita H; Kayagaki N; Kim KW; Lee MS
Eur J Immunol; 1999 Feb; 29(2):455-65. PubMed ID: 10064061
[TBL] [Abstract][Full Text] [Related]
5. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes.
Nakayama M; Nagata M; Yasuda H; Arisawa K; Kotani R; Yamada K; Chowdhury SA; Chakrabarty S; Jin ZZ; Yagita H; Yokono K; Kasuga M
Diabetes; 2002 May; 51(5):1391-7. PubMed ID: 11978635
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
[TBL] [Abstract][Full Text] [Related]
7. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
9. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
10. Soluble Fas ligand-susceptible "memory" cells in mice but not in human: potential role of soluble Fas ligand in deletion of auto-reactive cells.
Kim S; Ki JY; Lee TH; Suk K; Cha HS; Koh EM; Yagita H; Lee MS
Autoimmunity; 2002 Feb; 35(1):15-20. PubMed ID: 11908702
[TBL] [Abstract][Full Text] [Related]
11. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diabetes in the NOD mouse: an essential role of Fas-FasL signaling in beta cell apoptosis.
Silva DG; Socha L; Charlton B; Cowden W; Petrovsky N
Ann N Y Acad Sci; 2003 Nov; 1005():161-5. PubMed ID: 14679051
[TBL] [Abstract][Full Text] [Related]
14. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.
Itoh N; Imagawa A; Hanafusa T; Waguri M; Yamamoto K; Iwahashi H; Moriwaki M; Nakajima H; Miyagawa J; Namba M; Makino S; Nagata S; Kono N; Matsuzawa Y
J Exp Med; 1997 Aug; 186(4):613-8. PubMed ID: 9254659
[TBL] [Abstract][Full Text] [Related]
15. In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18.
Wen L; Green EA; Stratmann T; Panosa A; Gomis R; Eynon EE; Flavell RA; Mezquita JA; Mora C
Eur J Immunol; 2011 May; 41(5):1344-51. PubMed ID: 21469125
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
17. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
[TBL] [Abstract][Full Text] [Related]
19. The role of Fas in autoimmune diabetes.
Chervonsky AV; Wang Y; Wong FS; Visintin I; Flavell RA; Janeway CA; Matis LA
Cell; 1997 Apr; 89(1):17-24. PubMed ID: 9094710
[TBL] [Abstract][Full Text] [Related]
20. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
